CES 2023:OMRON Healthcare Introducing Initiatives to Advance Its Vision of "Going for Zero" -- Elimination of Heart Attack and Stroke

OMRON Healthcare Co., Ltd. (hereinafter the Company) will exhibit at CES 2OMRON Healthcare23 (), the world's largest consumer tech show taking place in Las Vegas from Thursday, January 5, through Sunday, January 8. At the show, the Company will showcase the innovative medical devices and digital services that have been introduced over the last 5OMRON Healthcare years and that have helped them advance the corporate vision of "Going for Zero" -- the elimination of heart attack and stroke. These initiatives include the innovative heart health devices such as Complete (TM), the upper-arm blood pressure monitor with built-in ECG technology, and their global remote patient-monitoring services. () Consumer Electronics Show

Logo: https://kyodonewsprwire.jp/img/202212121045-O1-sEo1c8K3

As part of the event, a media-only press conference will take place from 3pm to 3:45pm on January 4, 2023 (PST). Ranndy Kellogg, CEO of OMRON Healthcare, Inc., and other senior executives will present the initiatives that have propelled the Company into a solid leadership position in heart health.

In support of the event, a special website will be launched on Thursday, December 15, which will demonstrate the Company's business environments, exhibit themes, future vision, and latest clinical study results.

Themes at CES 2023

  1. Early detection of heart diseases by using Blood Pressure Monitoring + ECG technology
    Atrial Fibrillation (AFib) is a type of irregular heartbeat, known as an arrhythmia. Because its symptoms can be subtle, they can simply go unnoticed, and so it is difficult to detect the condition at an early stage. If left uncontrolled, AFib increases the risk of stroke by five times the average. OMRON has introduced the upper-arm blood pressure monitor with built-in ECG technology worldwide, with the aim of making daily vital ECG recording routine along with blood pressure measurement. The goal is to detect the risks of AFib at an early stage and prevent it from worsening, aiming to reduce the risk of heart attack and stroke while helping to advance the Company's vision of Going for Zero.
  2. Expansion of Digital Health
    OMRON connect (US/CAN/EMEA) is a health management mobile app. It analyzes the trends of users' vital data by using AI technology and suggests optimal lifestyle modification programs and other insights. OMRON connect will be demonstrated at OMRON's exhibit booth at CES 2023.
  3. Innovation of Global Remote Patient Monitoring (RPM) Services
    A new multi-disease RPM platform will be introduced in the UK. The service, scheduled to launch in early 2023, will help patients of chronic diseases share vital health data from their homes with their physicians. The service lets physicians monitor physical status and the medication adherence of their patients to improve chronic care management. In the UK, patients have an option to register with a General Practitioner (GP) who will care for a wide range of patients and conditions, from an initial visit to long-term treatment. As patients' conditions are managed using the platform, a GP's workload is shown to be reduced, while early detection of severe cerebrovascular and cardiovascular diseases can be expected. Additionally, the RPM service in the U.S., VitalSight (TM) by OMRON, will also be exhibiting to share treatment efficacies and health economics of their service, including physician testimonials.

Event overview
Dates: Thursday, Jan. 5, 2023 - Sunday, Jan. 8, 2023
Venue: Las Vegas Convention Center (LVCC)
Exhibition Style: Booth
Booth No: 8604
Coverage Site: https://healthcare.omron.com/ces2023

https://healthcare.omron.com/ (Global)

Source: OMRON Healthcare Co., Ltd.


ข่าวOMRON Healthcare+innovativeวันนี้

ออมรอน เฮลธแคร์ นำเสนอแบบประเมินคำนวณความเสี่ยงโรคหลอดเลือดสมอง พร้อมคำแนะนำบนเว็บไซต์ออมรอน เพื่อช่วยคนไทยป้องกันโรคร้ายได้ด้วยตนเอง

ออมรอน เฮลธแคร์ (OMRON Healthcare) บริษัทสาขาในประเทศไทยภายใต้บริษัทแม่ในญี่ปุ่นซึ่งเป็นผู้นำด้านอุปกรณ์การตรวจวัดความดันโลหิตที่บ้าน ได้นำเสนอแบบประเมิน คำนวณความเสี่ยงโรคหลอดเลือดสมอง (Stroke Risk Calculator) บนเว็บไซต์ ซึ่งเป็นเครื่องมือออนไลน์อันเปี่ยมประสิทธิภาพซึ่งถูกออกแบบมาเพื่อประเมินความเสี่ยงต่อโรคหลอดเลือดสมองรายบุคคลโดยมหาวิทยาลัยเทคโนโลยีโอ๊กแลนด์ ประเทศนิวซีแลนด์ โครงการส่งเสริมสุขภาพ ผ่านแบบประเมินความเสี่ยง เกิดจากความร่วมมือของผู้เชี่ยวชาญด้านโรคหลอดเลือดสมองกว่า 300 คนจาก 102

OMRON Healthcare Celebrates 50 Years of Blood Pressure Monitor History

OMRON Healthcare Co., Ltd. (hereinafter referred to as the Company) based in Muko City, Kyoto Prefecture, Japan, is proud to announce the celebration of its 50th anniversary in blood pressure monitor production this year. Since...

CES 2023: OMRON Healthcare to Unveil New Efforts to Realize Vision of "Going for Zero" -- Zero Heart Attacks and Zero Strokes

- "Viso," New UK Remote Patient Monitoring Service, to Be Launching in Early 2023 - OMRON Healthcare Co., Ltd. (hereinafter the Company) is unveiling a new UK remote patient...

CES 2023:OMRON Healthcare Introducing Initiatives to Advance Its Vision of "Going for Zero" -- Elimination of Heart Attack and Stroke

OMRON Healthcare Co., Ltd. (hereinafter the Company) will exhibit at CES 2023 (), the world's largest consumer tech show taking place in Las Vegas from Thursday,...

OMRON Healthcare Unveils Long-term Corporate Vision, "Going for ZERO, Preventive Care for Health of Society"

- Aiming to Realize 3 Zeros: "Zero Cerebrovascular and Cardiovascular Events," "Zero Aggravation of Respiratory Diseases" and "Zero Restrictions on Daily Activities Due to Chronic Pain" - In...

OMRON ลงทุนเพิ่มเติมใน AliveCor ผ่านการระดมทุนรอบ Series E ตอกย้ำความเป็นพันธมิตรระหว่างบริษัทในการจัดการภาวะโรคหัวใจและหลอดเลือดจากระยะไกล

บริษัท ออมรอน เฮลท์แคร์ จำกัด (OMRON Healthcare Co., Ltd.) ประกาศเพิ่มการลงทุนใน AliveCor โดยบริษัทแม่อย่าง OMRON Corporation เมื่อวันที่ 24 พฤศจิกายน ซึ่ง...

OMRON Strengthens Engagement with AliveCor with Series E Investment, Reinforces Cross-company Alliance for Remote Cardiovascular Condition Management

OMRON Healthcare Co., Ltd. announced on November 24 additional investment into AliveCor by its parent company, OMRON Corporation, as part of $65...